Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities
Abhinav Kanwal, Navjot Kanwar, Sanjay Bharati, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 331-331
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study
Shriram D. Ranade, Shankar G. Alegaon, Nayeem A. Khatib, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3162-3179
Open Access | Times Cited: 11
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity
Mohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106709-106709
Closed Access | Times Cited: 17
Stevia (Stevia rebaudiana) extract ameliorates insulin resistance by regulating mitochondrial function and oxidative stress in the skeletal muscle of db/db mice
Jin-Young Han, Miey Park, Hae‐Jeung Lee
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Nutritional interventions to manage diabetes complications associated with foodborne diseases: A comprehensive review
Edward Muita Mugo, Redempter Nzuma, Opeyemi Olaoluwa Tade, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 23, Iss. 1, pp. 2724-2736
Open Access | Times Cited: 4
Multi Targeted Activity of Cocculus hirsutus through Modulation of DPP-IV and PTP-1B Leading to Enhancement of Glucose Uptake and Attenuation of Lipid Accumulation
D. Bhuvaneswari, B Riitvek, Baddireddi Subhadra Lakshmi
Applied Biochemistry and Biotechnology (2025)
Closed Access
Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening
Bedriye Seda Kurşun Aktar, Yusuf Sıcak, Abdulkadir Bakırdöven, et al.
ACS Omega (2025) Vol. 10, Iss. 9, pp. 9368-9380
Open Access
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them
Prerna Uniyal, Surbhi Panwar, Anuj M. Bhatt, et al.
Molecular Diversity (2025)
Closed Access
Advances in small-molecule insulin secretagogues for diabetes treatment
Jingqian Su, Jingran Xu, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117179-117179
Open Access | Times Cited: 3
Ursonic acid from Artemisia montana exerts anti-diabetic effects through anti-glycating properties, and by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant C2C12 cells
Md Yousof Ali, Se Eun Park, Su Hui Seong, et al.
Chemico-Biological Interactions (2023) Vol. 376, pp. 110452-110452
Closed Access | Times Cited: 7
Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies
Samuel Álvarez-Almazán, Luz Cassandra Solís-Domínguez, Paulina Duperou-Luna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12812-12812
Open Access | Times Cited: 7
Natural Bioactive Compounds from Marine Invertebrates That Modulate Key Targets Implicated in the Onset of Type 2 Diabetes Mellitus (T2DM) and Its Complications
Marcello Casertano, Alessio Vito, Anna Aiello, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2321-2321
Open Access | Times Cited: 7
Promising Directions for Regulating Signaling Pathways Involved in the Type 2 Diabetes Mellitus Development (A Review)
N. A. Borozdina, I. A. Dyachenko, D. V. Popkova
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 4, pp. 1263-1284
Closed Access | Times Cited: 2
Identification of promising dipeptidyl pepti-dase-4 and protein tyrosine phosphatase 1B inhibitors from selected terpenoids through molecular modeling
Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Femi Olawale, et al.
Bioinformatics Advances (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
In Silico Exploration of Phytochemicals as Potential Drug Candidates against Dipeptidyl Peptidase-4 Target for the Treatment of Type 2 Diabetes
Sanjeev Singh, Sudhakar Kancharla, Prachetha Kolli, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2023) Vol. 7, Iss. 4, pp. 598-607
Open Access | Times Cited: 6
<i>In silico</i> Screening of Potential Antidiabetic Phenolic Compounds from Banana (<i>Musa</i> spp.) Peel Against PTP1B Protein
Rico Alexander Pratama, Junaida Astina, Arli Aditya Parikesit
Journal of Tropical Biodiversity and Biotechnology (2023) Vol. 8, Iss. 3, pp. 83124-83124
Open Access | Times Cited: 5
Network pharmacology combined with molecular docking and experimental verification to elucidate functional mechanism of Fufang Zhenzhu Tiaozhi against type 2 diabetes mellitus
Bo Li, Minghao Yin, Youyan Zeng, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-17
Open Access | Times Cited: 4
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances
Grzegorz Kazek, Monika Głuch‐Lutwin, Barbara Mordyl, et al.
(2024)
Open Access | Times Cited: 1
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access | Times Cited: 1
Coumarin derivatives against diabetics: a systematic target-specific drug repurposing approach via molecular docking-dynamic simulation
Priti Rani Sahu, Dhananjay Kumar Tanty, Susanta Kumar Sahu
Journal of Taibah University for Science (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Inhibitory effects of selected cannabinoids against dipeptidyl peptidase IV, an enzyme linked to type 2 diabetes
Lithalethu Mkabayi, Zenobia Viljoen, Rui W. M. Krause, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23289-e23289
Open Access | Times Cited: 3
The Application of High‐Throughput Approaches in Identifying Novel Therapeutic Targets and Agents to Treat Diabetes
Siyi He, Gareth E. Lim
Advanced Biology (2022) Vol. 7, Iss. 2
Closed Access | Times Cited: 5
Discovery of inhibitors of protein tyrosine phosphatase 1B contained in a natural products library from Mexican medicinal plants and fungi using a combination of enzymatic and in silico methods**
Miriam Díaz-Rojas, Martín González‐Andrade, Rodrigo Aguayo‐Ortiz, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus
Lei Huang, Bei Cao, Yan Geng, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 192, pp. 106644-106644
Open Access | Times Cited: 2
Analysis of the management and therapeutic performance of diabetes mellitus employing special target
Hongyan Sun, Xiaoyan Lin
World Journal of Diabetes (2023) Vol. 14, Iss. 12, pp. 1721-1737
Open Access | Times Cited: 2
Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances
Grzegorz Kazek, Monika Głuch‐Lutwin, Barbara Mordyl, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 229-229
Open Access
Page 1 - Next Page

Scroll to top